Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (27 ops.)
Latest filing published 23 Jan 2026 for Soleno Therapeutics INC.
Filing timeline
BuySalePatricia C. Hirano
Insider track record
Disclosed buys
1
Disclosed sells
27
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +12.4%Entry US$3.00 · Close at T+365 US$3.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Patricia C. Hirano: trading record in brief
All filings by Patricia C. Hirano on record concern Soleno Therapeutics Inc, in the capacity of chief executive. Over a trading history stretching from 23 January 2020 to 21 January 2026, the count stands at 38 filings.
On the open market, the record shows 1 purchase and 27 sales worth €2.4M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 9 share grants and 1 option exercise.
The latest filing, published on 23 January 2026, reports a share grant in Soleno Therapeutics Inc. The last insider purchase was made public on 4 April 2022, 1,664 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Patricia C. Hirano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
10,400 shares0Common StockSEC:0001766042-26-000001:0
904 shares@ US$49.952.5% of flowCommon StockSEC:0001766042-25-000003:0
3,830 shares@ US$82.7617.6% of flowCommon StockSEC:0001415889-25-019336:0
266 shares@ US$44.250.7% of flowCommon StockSEC:0001415889-25-018294:0
3,782 shares@ US$70.1116.1% of flowCommon StockSEC:0001415889-25-009740:0
1,418 shares@ US$65.96915.7% of flowCommon StockSEC:0001415889-25-009291:0
6,400 shares0Common StockSEC:0001415889-25-001933:0
1,447 shares@ US$45.36564.1% of flowCommon StockSEC:0001415889-25-000954:0
319 shares@ US$50.25Common StockSEC:0001415889-24-024659:1
2,789 shares@ US$49.33588.1% of flowCommon StockSEC:0001415889-24-024659:0
2,453 shares@ US$48.03Common StockSEC:0001415889-24-022649:1
4,426 shares@ US$47.16Common StockSEC:0001415889-24-022649:2
1,009 shares@ US$47.83Common StockSEC:0001415889-24-022649:3
2,817 shares@ US$47.19267.8% of flowCommon StockSEC:0001415889-24-022649:0
2,198 shares@ US$46.14Common StockSEC:0001415889-24-020944:1
587 shares@ US$43.64Common StockSEC:0001415889-24-020944:2
1,983 shares@ US$45.25Common StockSEC:0001415889-24-020944:3
3,407 shares@ US$45.89Common StockSEC:0001415889-24-020944:4
2,834 shares@ US$45.47677.7% of flowCommon StockSEC:0001415889-24-020944:0
85,000 shares0Common StockSEC:0001415889-24-019809:0
1,697 shares@ US$41.63Common StockSEC:0001415889-24-019268:1
473 shares@ US$41.22171.2% of flowCommon StockSEC:0001415889-24-019268:0
888 shares@ US$41.67Common StockSEC:0001415889-24-010245:1
1,330 shares@ US$41.12273.3% of flowCommon StockSEC:0001415889-24-010245:0
832 shares@ US$48.302.4% of flowCommon StockSEC:0001415889-24-001927:0
25 of 37 declarations
